Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K/Akt signaling pathway.
- DOI
- 10.1016/j.intimp.2019.105734
- Published
- 2019 Oct
- Container
- International immunopharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 25/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.intimp.2019.105734,
title = {Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K/Akt signaling pathway.},
author = {Cai L and Tu L and Li T and Yang X and Ren Y and Gu R and Zhang Q and Yao H and Qu X and Wang Q and Tian J},
year = {2019},
journal = {International immunopharmacology},
doi = {10.1016/j.intimp.2019.105734},
url = {https://doi.org/10.1016/j.intimp.2019.105734}
}RIS
TY - JOUR TI - Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K/Akt signaling pathway. AU - Cai L AU - Tu L AU - Li T AU - Yang X AU - Ren Y AU - Gu R AU - Zhang Q AU - Yao H AU - Qu X AU - Wang Q AU - Tian J PY - 2019 JO - International immunopharmacology DO - 10.1016/j.intimp.2019.105734 UR - https://doi.org/10.1016/j.intimp.2019.105734 ER -
APA
L, C., L, T., T, L., X, Y., Y, R., R, G., Q, Z., H, Y., X, Q., Q, W., & J, T. (2019). Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K/Akt signaling pathway.. International immunopharmacology. https://doi.org/10.1016/j.intimp.2019.105734
Source records
- pubmed · retrieved 2026-09-25T01:59:39.614Z